Cargando…

Plasma Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful Antiretroviral Therapy

Targeted metabolomics studies reported metabolic abnormalities in both treated and untreated people living with human immunodeficiency virus (HIV) (PLHIV). The present study aimed to understand the plasma metabolomic changes and predicted the risk of accelerated aging in PLHIV on long-term suppressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babu, Hemalatha, Sperk, Maike, Ambikan, Anoop T., Rachel, Gladys, Viswanathan, Vinod Kumar, Tripathy, Srikanth P., Nowak, Piotr, Hanna, Luke Elizabeth, Neogi, Ujjwal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835959/ https://www.ncbi.nlm.nih.gov/pubmed/31574898 http://dx.doi.org/10.3390/metabo9100210

Ejemplares similares

Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy
por: Babu, Hemalatha, et al.
Publicado: (2019)

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
por: Sperk, Maike, et al.
Publicado: (2021)

Plasma soluble factor following two decades prolonged suppressive antiretroviral therapy in HIV-1-positive males: A cross-sectional study
por: Sperk, Maike, et al.
Publicado: (2018)

Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers
por: Zhang, Wang, et al.
Publicado: (2017)

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
por: Ambikan, Anoop T, et al.
Publicado: (2022)

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2021)

Publisher Correction: In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashokkumar, Manickam, et al.
Publicado: (2020)

In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashok kumar, Manickam, et al.
Publicado: (2020)

Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2022)

Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2023)

Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection
por: Sperk, Maike, et al.
Publicado: (2018)

MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors
por: Aralaguppe, Shambhu G., et al.
Publicado: (2019)

Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
por: Obasa, Adetayo Emmanuel, et al.
Publicado: (2021)

Biological Aging in People Living with HIV on Successful Antiretroviral Therapy: Do They Age Faster?
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2023)

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
por: Appelberg, Sofia, et al.
Publicado: (2020)

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
por: Ray, Shilpa, et al.
Publicado: (2020)

Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy
por: Bai, Xiangning, et al.
Publicado: (2021)

Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
por: Mikaeloff, Flora, et al.
Publicado: (2022)

Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
por: Ambikan, Anoop T., et al.
Publicado: (2022)

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
por: Krishnan, Shuba, et al.
Publicado: (2021)

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications
por: Acharya, Arpan, et al.
Publicado: (2023)

Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management
por: Grossmann, Sebastian, et al.
Publicado: (2015)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
por: Neogi, Ujjwal, et al.
Publicado: (2020)

Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach
por: Natarajan, Sudhakar, et al.
Publicado: (2022)

Emergence of HIV-1 drug resistance in antiretroviral therapy experienced perinatally infected children in South India
por: Neogi, Ujjwal, et al.
Publicado: (2012)

Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
por: Sperk, Maike, et al.
Publicado: (2020)

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
por: Häggblom, Amanda, et al.
Publicado: (2017)

Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women
por: Munusamy Ponnan, Sivasankaran, et al.
Publicado: (2021)

Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India
por: Vidyavijayan, K. K., et al.
Publicado: (2018)

Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy
por: Zhang, Wang, et al.
Publicado: (2017)

Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort Study
por: Neogi, Ujjwal, et al.
Publicado: (2013)

Impact of Long COVID on health and quality of life
por: O’ Mahony, Liam, et al.
Publicado: (2022)

The expanding HIV-1 epidemic aggravates therapeutics and vaccine development programs in India
por: Neogi, Ujjwal
Publicado: (2009)

CRUSADE FOR TB: Bringing Treatment to Masses at their Doorsteps
por: Natrajan, Mohan, et al.
Publicado: (2019)

Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains
por: Cheedarla, Narayanaiah, et al.
Publicado: (2018)

Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
por: Sinha, Sanjeev, et al.
Publicado: (2017)

Elevated Numbers of HIV-Specific Poly-Functional CD8(+) T Cells With Stem Cell-Like and Follicular Homing Phenotypes in HIV-Exposed Seronegative Individuals
por: Munusamy Ponnan, Sivasankaran, et al.
Publicado: (2021)

Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals
por: Neogi, Ujjwal, et al.
Publicado: (2013)

Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection
por: Ambikan, Anoop T., et al.
Publicado: (2023)

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
por: Neogi, Ujjwal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sfu5rtmsrrr7ip9altgmb5eki7